Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Sunshine Biopharma (SBFM) over the last 14 years, with Q3 2025 value amounting to $4.6 million.

  • Sunshine Biopharma's Shares Outstanding (Weighted Average) rose 25942.5% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 25942.5%. This contributed to the annual value of $701749.0 for FY2024, which is 537172.71% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Shares Outstanding (Weighted Average) of $4.6 million as of Q3 2025, which was up 25942.5% from $4.5 million recorded in Q2 2025.
  • Sunshine Biopharma's Shares Outstanding (Weighted Average)'s 5-year high stood at $18.9 million during Q3 2022, with a 5-year trough of $12675.0 in Q2 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Weighted Average) was $2.4 million (2021), whereas its average is $4.2 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first plummeted by 9993.2% in 2023, then skyrocketed by 976815.88% in 2024.
  • Sunshine Biopharma's Shares Outstanding (Weighted Average) (Quarter) stood at $2.6 million in 2021, then skyrocketed by 481.18% to $15.2 million in 2022, then crashed by 99.92% to $12825.0 in 2023, then skyrocketed by 5371.73% to $701749.0 in 2024, then surged by 549.23% to $4.6 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $4.6 million for Q3 2025, versus $4.5 million for Q2 2025 and $2.7 million for Q1 2025.